PHCUF:OTCMKTS
Photocure ASA
$5.65
0.00%
(0.00) 1D
Sep 11, 11:24:53 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PHCUF...
Avg. vol.
33.00
Volume
0.00
52-wk high
$7.39
52-wk low
$5.65
Beta
0.08
Shares outstanding
27.12M
No. of employees
100
Avg. vol.
33.00
Volume
0.00
52-wk high
$7.39
52-wk low
$5.65
Beta
0.08
Shares outstanding
27.12M
No. of employees
100
News stories
From web sources and news partners
marketscreener.com
·
28 minutes ago
S&P 500 index showed little change after Stockholm market close
Stocktwits
·
49 minutes ago
How Are Dow, S&P 500, Nasdaq Futures Trading After SpaceX Earnings?
Yahoo Finance
·
2 hours ago
How Long Could You Wait for the S&P 500 to Recover From a 10% Drop?
Insider Monkey
·
11 hours ago
Ciena (CIEN): Is the AI-Optical Boom Enough to Carry It Into the S&P 500?
Profile
Photocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. Photocure's strategy in cancer is to continue the commercialization of Hexvix for bladder cancer diagnostics, and continue the development of the cancer portfolio and out-license prior to phase III studies. This strategy is based on a strong platform of intellectual property in photodynamic therapy. Wikipedia
About Photocure ASA